Evidence map›Paper›PMID 31893589›Full record

ArticleTurkish journal of ophthalmology2019

Comparative Biochemical Outcomes, Effectiveness and Tolerance of Densiron 68 and Oxane HD for the Management of Complicated Retinal Detachment

Chafik Keilani, Edouard Augstburger, Mathieu Robin, Amélie Beaugrand, Raphaëlle Ores, José-Alain Sahel, Sarah Ayello-Scheer

Open access · diamondAbstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Turkish journal of ophthalmology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Chafik KeilaniQuinze-Vingts National Hospital, Department of Ophthalmology IV / Sorbonne University, Faculty of Medicine Pierre-et-Marie-Curie/Assistance Publique-Hopitaux de Paris, Paris, FranceORCID 0000-0002-7639-8030
Edouard AugstburgerQuinze-Vingts National Hospital, Department of Ophthalmology III, Paris, FranceORCID 0000-0002-7296-2343
Mathieu RobinQuinze-Vingts National Hospital, Department of Ophthalmology III, Paris, FranceORCID 0000-0003-4423-6632
Amélie BeaugrandQuinze-Vingts National Hospital, Department of Biomedical Informatics, Paris, FranceORCID 0000-0001-5321-9661
Raphaëlle OresQuinze-Vingts National Hospital, Department of Ophthalmology, Paris, FranceORCID 0000-0001-6937-0198
José-Alain SahelQuinze-Vingts National Hospital, Department of Ophthalmology, Paris, FranceORCID 0000-0003-3600-3599
Sarah Ayello-ScheerQuinze-Vingts National Hospital, Department of Ophthalmology, Paris, FranceORCID 0000-0003-2907-4452
Centre hospitalier national d'ophtalmologie des Quinze-Vingts · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To compare biochemical outcomes, effectiveness, and tolerance of two high-density silicone oils (HDSOs), silicone oil- RMN3 (Oxane Materials and Methods: This was a retrospective, single-centre, comparative case series of 23 patients treated between September 2014 and June 2016. The main inclusion criteria were RD with inferior PVR receiving Oxane Results: Twenty-three eyes were included: 16 eyes with Densiron Conclusion: Densiron

Indexed as

VitrectomyAgedEndotamponadeFemaleHumansMaleMiddle AgedRetinal DetachmentRetrospective StudiesSilicone OilsTreatment OutcomeVisual AcuityVitreoretinopathy, Proliferativedensiron-68oxane HDSilicone Oilscomplicated inferior retinal detachmentDensiron® 68High-density silicone oilsOxane® HDproliferative vitreoretinopathy

Identifiers

PMID31893589
PMCPMC6961081
OpenAlexW2996949449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.